European stock markets remain calm, although several European countries have announced worrying rises in infections.
Even the bond market stabilized following ECB’s announcement regarding an increase to its asset purchase program rate. The European Central Bank chief economist has made reassuring statements that the ECB still has enough room to extend its expansionary monetary policy even with interest rate cuts. This is nothing new, as the market already took that into account. However, it could be necessary for the monetary policy committee to put it into practice.
In any case, everything will depend on what the Federal Reserve will announce after tomorrow's meeting. If they do not show a firm determination to curb the outflows of fixed income, the effect of long-term rate hikes could resume and move to European markets as well.
While the rate of vaccination in the United States continues to grow, Europe’s vaccination target of 70% has been questioned, potentially leading to a significant setback for the economy and its quest for recovery.
In this scenario, the euro could remain stable. EUR/USD hovers around the 100-hour SMA line in a range that could take a clearer direction tomorrow after the Federal Reserve meeting.
The same goes for European indices. For example, Germany30 remains in a lateral movement near its highs, but the RSI got close to the daily chart's overbought zone.
Sources: Investing.com, Forelive.com.
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research.
Key Way Investments Ltd does not influence nor has any input in formulating the information contained herein. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.